Skip to main content

Table 1 Table of data extractions from 16 articles included in the study

From: Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis

Author

Year of publication

Study type

Localization

Study duration years

HR/RR

Number of patients in the cohort

Number of patients with PH

Number of deceased patients

Number of deceased patients with PH

Al-Dhaher, F. F

2010

Cohort

USA

10

2.70 [1.00, 7.29]

185

19

42

9

Chung, M. P

2020

Cohort

USA

10

2.33 [1.48, 3.68]

609

50

105

16

Hachulla, E

2009

Cohort

France

3

7.25 [4.00, 13.12]

546

47

47

20

Hashimoto, A

2011

Cohort

Japan

Retrospective

2.39 [1.65, 3.46]

405

65

86

27

Hesselstrand,R

2011

Cohort

Sweden

7

3.20 [1.80, 5.69]

180

30

-

-

Hissaria, P

2011

Cohort

Australia

15

2.17 [1.40,3.36]

786

65

331

-

Hoffmann-Vold

2013

Cohort

Norway

11

8.00 [3.40, 18.82]

312

34

43

8

Hsu, V. M

2019

Cohort

USA

4 (0.4–8.5)

2.99 [1.30, 6.88]

236

35

32

7

Hu, S

2018

Cohort

China

10

6.25 [2.86, 13.67]

448

78

40

22

Joven, B. E

2010

Cohort

Spain

8

2.20 [1.20, 4.03]

204

59

44

11

Moon, K. W

2018

Cohort

Korea

Retrospective

4.66 [2.57, 8.45]

751

102

57

-

Noviani, M

2020

Cohort

Singapore

8.8

2.39 [1.13, 5.06]

490

50

-

-

Panopoulos, S

2018

Cohort

Greece

8.5 ± 4

7.49 [1.70, 33.00]

115

16

23

6

Rubio-Rivas M

2018

Cohort

Spain

Retrospective

1.68 [1.29,2.19]

1625

311

277

43

Simeon-Aznar

2015

Cohort

Spain

Retrospective

2.69 [1.73, 4.17]

879

161

138

58

Trad, S

2006

Cohort

France

6

4.09 [1.47, 11.38]

86

18

17

9

  1. HR: Hazard ratio, RR: Risk Ratio, PH: pulmonary hypertension